BGI has been a pioneer in developing genomics based solutions across the reproductive health continuum.
Our market leading non-invasive prenatal test (NIPT), the NIFTY® test, was one of the first NIPTs on the market and has been trusted by over 1.5 million patients worldwide.
BGI also offers a wide range of other genetics tests including carrier screening, newborn screening for rare disease and PGS.
We continue to support and be involved in a wide range of research connected to maternal and child health, working with a wide range of partners across the world.
*Tests are subject to regional availability and not available in the USA.